Open Nav

InMed Pharmaceuticals Inc.

  • Eric Adams, InMed Pharmaceuticals Inc.

Present pipeline to potential partners

  • Date:Wednesday, October 17
  • Time:9:30 AM - 9:45 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:InMed Pharmaceuticals is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
  • Company
  • Company HQ City:Vancouver
  • Company HQ Country:Canada
  • Company HQ State:British Columbia
  • Market Cap:US$100 M +
  • Ticker:IMLFF
  • Exchange:OTCQX
  • CEO/Top Company Official:Eric A Adams
  • Main Therapeutic Focus:Orphan/Rare Diseases
  • Lead Product in Development :INM-750 For Epidermolysis Bullosa
  • Development Phase of Primary Product:Pre-Clinical
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :2-3
Eric Adams
InMed Pharmaceuticals Inc.